Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2003 Aug;41(8):3602-8.
doi: 10.1128/JCM.41.8.3602-3608.2003.

Identification of swine hepatitis E virus (HEV) and prevalence of anti-HEV antibodies in swine and human populations in Korea

Affiliations
Comparative Study

Identification of swine hepatitis E virus (HEV) and prevalence of anti-HEV antibodies in swine and human populations in Korea

In-Soo Choi et al. J Clin Microbiol. 2003 Aug.

Abstract

The swine hepatitis E virus (HEV) is considered to be a new zoonotic agent due to its close genomic resemblance to the human HEV and its ability to infect nonhuman primates. Hepatitis caused by HEV infection has been a serious public health problem in developing countries. However, recent seroprevalence studies indicate that the HEV also circulates in industrialized countries. In this study, a nested reverse transcription (RT)-PCR was developed to detect a part of the swine HEV open reading frame 2. Three Korean isolates of swine HEV were identified in 128 swine sera (2.3% prevalence) by the nested RT-PCR method. They were isolated from 2- to 3-month old pigs showing an age-specific prevalence of the HEV viremia. A phylogenetic tree analysis with a number of swine and human HEV isolates indicated that all Korean isolates of the swine HEV belong to genotype III. They were closely related to the swine and human HEV isolates that were identified in the United States and Japan. In addition, they formed a distinct branch in genotype III, showing a 92.7 to 99.8% identity at their nucleotide sequences. The overall prevalence of anti-swine HEV antibodies in swine was 15%. Antibodies to the swine HEV were not detected in 1-month-old pigs. However, the anti-swine HEV antibodies appeared in pigs older than 1 month and also showed an age-specific prevalence. The antibody prevalence rates to the swine HEV were 6.0, 10.0, 36.0, and 25.0%, in 2-, 3-, 4-, and 5-to-7-month-old pigs, respectively. In addition, the seroprevalence in sows to the swine HEV was 8.8%. On the other hand, 18% of blood donors in Korea were found to be positive for anti-HEV antibodies. Overall, this study indicates that subclinical HEV infections may prevail in swine and human populations in Korea.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Identification of the Korean isolates of swine HEV in swine sera. HEV RNA was purified from swine serum. A nested RT-PCR was then performed to amplify a region of swine HEV ORF2. The swine HEV-specific 860-bp DNA bands were identified from three pig sera. Lanes: M, standard 100-bp DNA ladder; 1, Korean isolate 1 of swine HEV (swKOR1; GenBank accession number of AF516178); 2, swKOR2 (AF516179); 3, swKOR3 (AF527942).
FIG. 2.
FIG. 2.
Phylogenetic tree analysis of the Korean isolates of swine HEV by comparison of the conserved 300 bp of the ORF2 in the swine and human HEV isolates. The HEV genotyping was determined according to a recent report (37). The GenBank accession numbers of the HEV isolates used in this study are indicated in Materials and Methods.
FIG. 3.
FIG. 3.
Age-dependent distribution of anti-HEV antibodies in swine sera. The presence of anti-HEV antibodies was examined with a commercial HEV IgG ELISA kit (Genelabs Diagnostics, Singapore) according to the manufacturer's instructions. Samples showing an optical density (OD) value greater than 0.54 were considered to be HEV positive. The cutoff value was determined by a calculation suggested in the manufacturer's instructions.

References

    1. Aggarwal, R., and K. Krawczynski. 2000. Hepatitis E: an overview and recent advances in clinical and laboratory research. J. Gastroenterol. Hepatol. 15:9-20. - PubMed
    1. Arankalle, V. A., M. K. Goverdhan, and K. Banerjee. 1994. Antibodies against hepatitis E virus in Old World monkeys. J. Viral. Hepat. 1:125-129. - PubMed
    1. Arankalle, V. A., M. S. Chadha, S. A. Tsarev, S. U. Emerson, A. R. Risbud, K. Banerjee, and R. H. Purcell. 1994. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc. Natl. Acad. Sci. USA 91:3428-3432. - PMC - PubMed
    1. Arankalle, V. A., S. A. Tsarev, M. S. Chadha, D. W. Alling, S. U. Emerson, K. Banerjee, and R. H. Purcell. 1995. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J. Infect. Dis. 171:447-450. - PubMed
    1. Arankalle, V. A., S. Paranjape, S. U. Emerson, R. H. Purcell, and A. M. Walimbe. 1999. Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). J. Gen. Virol. 80:1691-1700. - PubMed

Publication types

Substances

LinkOut - more resources